JP2023538129A - 好ましい発現レベルを有するアデノ随伴ウイルス組成物 - Google Patents
好ましい発現レベルを有するアデノ随伴ウイルス組成物 Download PDFInfo
- Publication number
- JP2023538129A JP2023538129A JP2023512697A JP2023512697A JP2023538129A JP 2023538129 A JP2023538129 A JP 2023538129A JP 2023512697 A JP2023512697 A JP 2023512697A JP 2023512697 A JP2023512697 A JP 2023512697A JP 2023538129 A JP2023538129 A JP 2023538129A
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid selected
- aav capsid
- further provided
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063068614P | 2020-08-21 | 2020-08-21 | |
| US63/068,614 | 2020-08-21 | ||
| PCT/US2021/046904 WO2022040527A2 (en) | 2020-08-21 | 2021-08-20 | Adeno-associated virus compositions having preferred expression levels |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023538129A true JP2023538129A (ja) | 2023-09-06 |
| JP2023538129A5 JP2023538129A5 (cg-RX-API-DMAC7.html) | 2024-08-28 |
Family
ID=80323313
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023512697A Pending JP2023538129A (ja) | 2020-08-21 | 2021-08-20 | 好ましい発現レベルを有するアデノ随伴ウイルス組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230303630A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4199972A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023538129A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117321213A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021329527A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3192600A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022040527A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113166208B (zh) | 2018-10-02 | 2024-11-22 | 沃雅戈治疗公司 | 重新定向aav衣壳的嗜性 |
| US12630842B2 (en) | 2020-05-13 | 2026-05-19 | Voyager Therapeutics, Inc. | Redirection of tropism of AAV capsids |
| EP4322976A4 (en) * | 2021-04-13 | 2025-06-25 | Capsida, Inc. | AAV COMPOSITIONS WITH HIGH EXPRESSION LEVELS IN THE BRAIN |
| KR20240095539A (ko) | 2021-10-08 | 2024-06-25 | 디노 테라퓨틱스, 인코포레이티드 | 캡시드 변이체 및 이의 사용 방법 |
| EP4426716A1 (en) | 2021-11-02 | 2024-09-11 | Voyager Therapeutics, Inc. | Aav capsid variants and uses thereof |
| CN119095867A (zh) * | 2022-03-24 | 2024-12-06 | 卡西达公司 | 具有优选的脑富集的所选aav组合物 |
| CN114774373B (zh) * | 2022-04-27 | 2024-07-05 | 北京市农林科学院 | 信鸽新城疫病毒基因工程改造弱毒株及其制备方法和应用 |
| EP4269426A1 (en) * | 2022-04-29 | 2023-11-01 | Ospedale San Raffaele S.r.l. | Gene therapy |
| WO2023215546A2 (en) * | 2022-05-06 | 2023-11-09 | Capsida, Inc. | Adeno-associated virus compositions having increased brain enrichment |
| EP4526325A4 (en) * | 2022-05-17 | 2026-08-05 | Capsida Inc | SELECTED ADENE-ASSOCIATED VIRUS COMPOSITIONS HAVING PREFERRED LEVELS OF CEREBRAL, SPINAL CORD AND/OR CARDIAC EXPRESSION |
| WO2023244919A1 (en) * | 2022-06-16 | 2023-12-21 | Capsida, Inc. | Adeno-associated virus compositions having increased brain enrichment and decreased liver enrichment |
| AU2023363990A1 (en) * | 2022-10-19 | 2025-05-08 | Capsida Biotherapeutics, Inc. | Adeno-associated virus compositions having preferred brain enrichment and low liver enrichment |
| AU2023364350A1 (en) | 2022-10-19 | 2025-06-05 | Affinia Therapeutics Inc. | Recombinant aavs with improved tropism and specificity |
| JP2026509271A (ja) | 2023-03-10 | 2026-03-17 | ダイノ セラピューティクス,インコーポレーテッド | カプシドポリペプチドおよびその使用方法 |
| CN120660140A (zh) * | 2023-03-27 | 2025-09-16 | 浙江大学 | 氨基酸序列的生成与筛选方法及其系统 |
| KR20260045798A (ko) * | 2023-06-30 | 2026-04-03 | 캡시다 바이오테라퓨틱스, 인크. | 증가된 뇌 풍부화를 갖는 아데노-연관 바이러스 조성물 |
| KR20260082361A (ko) | 2023-08-31 | 2026-06-04 | 디노 테라퓨틱스, 인코포레이티드 | 캡시드 폴리펩타이드 및 이의 사용 방법 |
| TW202545971A (zh) | 2024-02-08 | 2025-12-01 | 美商戴諾治療公司 | 殼體多肽及其使用方法 |
| WO2025213066A1 (en) * | 2024-04-05 | 2025-10-09 | Capsida Biotherapeutics, Inc. | Adeno-associated virus compositions for treating parkinson's disease (pd) |
| WO2025231383A1 (en) * | 2024-05-03 | 2025-11-06 | Capsida Biotherapeutics, Inc. | Compositions and methods of delivering a therapeutic across the blood-brain barrier via the pl16 receptor |
| WO2026064442A2 (en) | 2024-09-18 | 2026-03-26 | Dyno Therapeutics, Inc. | Capsid polypeptides and methods of use thereof |
| WO2026122963A1 (en) | 2024-12-06 | 2026-06-11 | Dyno Therapeutics, Inc. | Capsid polypeptides and methods of use thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2017513486A (ja) * | 2014-04-17 | 2017-06-01 | ウニヴェルズィテーツクリニクム ハンブルク−エッペンドルフUniversitaetsklinikum Hamburg−Eppendorf | 脳および脊髄に標的化遺伝子移入するためのウイルスベクター |
| JP2019506141A (ja) * | 2015-12-11 | 2019-03-07 | カリフォルニア インスティチュート オブ テクノロジー | アデノ随伴ウイルス(aav)を誘導するための標的指向性ペプチド |
| WO2020028751A2 (en) * | 2018-08-03 | 2020-02-06 | Voyager Therapeutics, Inc. | Aav variants with enhanced tropism |
| WO2020068990A1 (en) * | 2018-09-26 | 2020-04-02 | California Institute Of Technology | Adeno-associated virus compositions for targeted gene therapy |
| WO2020072683A1 (en) * | 2018-10-02 | 2020-04-09 | Voyager Therapeutics, Inc. | Redirection of tropism of aav capsids |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6710036B2 (en) * | 1997-07-25 | 2004-03-23 | Avigen, Inc. | Induction of immune response to antigens expressed by recombinant adeno-associated virus |
| DK3693025T3 (da) * | 2011-04-22 | 2022-01-10 | Univ California | Adenoassocierede virus-virioner med variant capsid og fremgangsmåder til anvendelse heraf |
| CN109640949B (zh) * | 2016-07-29 | 2022-11-25 | 加利福尼亚大学董事会 | 具有变异衣壳的腺相关病毒病毒体和其使用方法 |
| JP2021530218A (ja) * | 2018-07-11 | 2021-11-11 | ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッドThe Brigham and Women’s Hospital, Inc. | 血液脳関門を超える薬剤の送達のための方法および組成物 |
| US12281321B2 (en) * | 2018-09-28 | 2025-04-22 | Voyager Therapeutics, Inc. | Frataxin expression constructs having engineered promoters and methods of use thereof |
-
2021
- 2021-08-20 EP EP21859200.4A patent/EP4199972A4/en active Pending
- 2021-08-20 CA CA3192600A patent/CA3192600A1/en active Pending
- 2021-08-20 CN CN202180071840.5A patent/CN117321213A/zh active Pending
- 2021-08-20 JP JP2023512697A patent/JP2023538129A/ja active Pending
- 2021-08-20 WO PCT/US2021/046904 patent/WO2022040527A2/en not_active Ceased
- 2021-08-20 US US18/022,056 patent/US20230303630A1/en active Pending
- 2021-08-20 AU AU2021329527A patent/AU2021329527A1/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2017513486A (ja) * | 2014-04-17 | 2017-06-01 | ウニヴェルズィテーツクリニクム ハンブルク−エッペンドルフUniversitaetsklinikum Hamburg−Eppendorf | 脳および脊髄に標的化遺伝子移入するためのウイルスベクター |
| JP2019506141A (ja) * | 2015-12-11 | 2019-03-07 | カリフォルニア インスティチュート オブ テクノロジー | アデノ随伴ウイルス(aav)を誘導するための標的指向性ペプチド |
| WO2020028751A2 (en) * | 2018-08-03 | 2020-02-06 | Voyager Therapeutics, Inc. | Aav variants with enhanced tropism |
| WO2020068990A1 (en) * | 2018-09-26 | 2020-04-02 | California Institute Of Technology | Adeno-associated virus compositions for targeted gene therapy |
| WO2020072683A1 (en) * | 2018-10-02 | 2020-04-09 | Voyager Therapeutics, Inc. | Redirection of tropism of aav capsids |
Also Published As
| Publication number | Publication date |
|---|---|
| CN117321213A (zh) | 2023-12-29 |
| EP4199972A2 (en) | 2023-06-28 |
| CA3192600A1 (en) | 2022-02-24 |
| US20230303630A1 (en) | 2023-09-28 |
| EP4199972A4 (en) | 2025-01-15 |
| WO2022040527A2 (en) | 2022-02-24 |
| WO2022040527A3 (en) | 2022-05-05 |
| AU2021329527A1 (en) | 2023-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20250179441A1 (en) | Adeno-associated virus compositions for targeted gene therapy | |
| US20230303630A1 (en) | Adeno-associated virus compositions having preferred expression levels | |
| JP2024513949A (ja) | 脳内発現レベルが高いaav組成物 | |
| US20250281643A1 (en) | Selected aav compositions having preferred brain enrichment | |
| US20250082779A1 (en) | Adeno-associated virus compositions having increased brain enrichment | |
| CN114127090A (zh) | 在大脑中具有增强的特异性的病毒组合物 | |
| US20250249124A1 (en) | Adeno-associated virus compositions having increased brain enrichment | |
| KR20250017219A (ko) | 바람직한 뇌, 척수, 및/또는 심장 발현 수준을 갖는 선택된 아데노-연관 바이러스 조성물 | |
| US20250001007A1 (en) | Adeno-associated virus compositions having preferred heart and skeletal muscle enrichment | |
| KR20240162556A (ko) | 바람직한 뇌 풍부화를 갖는 선택된 aav 조성물 | |
| US20260139010A1 (en) | Adeno-associated virus compositions having preferred brain enrichment and low liver enrichment | |
| US20250346637A1 (en) | Adeno-associated virus compositions having increased brain enrichment and decreased liver enrichment | |
| KR20240162557A (ko) | 증가된 심장 풍부화를 갖는 아데노-연관 바이러스 조성물 | |
| KR20260045798A (ko) | 증가된 뇌 풍부화를 갖는 아데노-연관 바이러스 조성물 | |
| WO2025106565A1 (en) | Adeno-associated virus compositions having increased central nervous system, brain, and/or spinal cord enrichment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240820 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20240820 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20250801 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20251031 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20251225 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20260202 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20260601 |